Cargando…

Antiarrhythmic Drug Dosing in Children—Review of the Literature

Antiarrhythmic drugs represent a mainstay of pediatric arrhythmia treatment. However, official guidelines and consensus documents on this topic remain scarce. There are rather uniform recommendations for some medications (including adenosine, amiodarone, and esmolol), while there are only very broad...

Descripción completa

Detalles Bibliográficos
Autores principales: Oeffl, Nathalie, Schober, Lukas, Faudon, Patrick, Schweintzger, Sabrina, Manninger, Martin, Köstenberger, Martin, Sallmon, Hannes, Scherr, Daniel, Kurath-Koller, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217455/
https://www.ncbi.nlm.nih.gov/pubmed/37238395
http://dx.doi.org/10.3390/children10050847
Descripción
Sumario:Antiarrhythmic drugs represent a mainstay of pediatric arrhythmia treatment. However, official guidelines and consensus documents on this topic remain scarce. There are rather uniform recommendations for some medications (including adenosine, amiodarone, and esmolol), while there are only very broad dosage recommendations for others (such as sotalol or digoxin). To prevent potential uncertainties and even mistakes with regard to dosing, we summarized the published dosage recommendations for antiarrhythmic drugs in children. Because of the wide variations in availability, regulatory approval, and experience, we encourage centers to develop their own specific protocols for pediatric antiarrhythmic drug therapy.